These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18342277)
1. New antimalarial targets: the example of glucose transport. Patel AP; Staines HM; Krishna S Travel Med Infect Dis; 2008; 6(1-2):58-66. PubMed ID: 18342277 [TBL] [Abstract][Full Text] [Related]
2. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds. Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322 [TBL] [Abstract][Full Text] [Related]
3. Why is the Plasmodium falciparum hexose transporter a promising new drug target? Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822 [TBL] [Abstract][Full Text] [Related]
4. The hexose transporter of Plasmodium falciparum is a worthy drug target. Joët T; Krishna S Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563 [TBL] [Abstract][Full Text] [Related]
5. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT). Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282 [TBL] [Abstract][Full Text] [Related]
6. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria]. Ellekvist P; Colding H Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884 [TBL] [Abstract][Full Text] [Related]
7. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering. Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153 [TBL] [Abstract][Full Text] [Related]
8. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters. Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766 [TBL] [Abstract][Full Text] [Related]
9. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Joet T; Eckstein-Ludwig U; Morin C; Krishna S Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024 [TBL] [Abstract][Full Text] [Related]
10. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir. Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development. Deniskin R; Frame IJ; Sosa Y; Akabas MH Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473 [TBL] [Abstract][Full Text] [Related]
12. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality. Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450 [TBL] [Abstract][Full Text] [Related]
13. Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa. Slavic K; Krishna S; Derbyshire ET; Staines HM Malar J; 2011 Jun; 10():165. PubMed ID: 21676209 [TBL] [Abstract][Full Text] [Related]
14. An overview of the Plasmodium falciparum hexose transporter and its therapeutic interventions. Jiang X Proteins; 2022 Oct; 90(10):1766-1778. PubMed ID: 35445447 [TBL] [Abstract][Full Text] [Related]
15. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum. Jiang X; Yuan Y; Huang J; Zhang S; Luo S; Wang N; Pu D; Zhao N; Tang Q; Hirata K; Yang X; Jiao Y; Sakata-Kato T; Wu JW; Yan C; Kato N; Yin H; Yan N Cell; 2020 Oct; 183(1):258-268.e12. PubMed ID: 32860739 [TBL] [Abstract][Full Text] [Related]
16. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203 [TBL] [Abstract][Full Text] [Related]
17. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax. Bustamante C; Batista CN; Zalis M Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564 [TBL] [Abstract][Full Text] [Related]
18. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives. Fayolle M; Ionita M; Krishna S; Morin C; Patel AP Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099 [TBL] [Abstract][Full Text] [Related]
19. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum. Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103 [TBL] [Abstract][Full Text] [Related]
20. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum. Qidwai T; Khan F Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]